Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuanhu Zhitong Pian is a traditional Chinese medicine (TCM) formulation developed and manufactured by Jiangsu Tiansheng Pharmaceutical. It is primarily composed of *Corydalis yanhusuo* (Yuanhu) and *Angelica dahurica* (Baizhi). According to traditional Chinese medicine principles, the formulation is used to regulate qi, promote blood circulation, and alleviate pain associated with qi stagnation and blood stasis. Clinical indications include stomachache, rib pain, headache, and dysmenorrhea. As a TCM product, its efficacy is attributed to the synergistic effects of its botanical constituents rather than a single molecular target, though *Corydalis* is known to contain alkaloids with analgesic properties. The product is approved in China and administered orally as tablets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yuanhu zhitong pian.